PSIL ETF
ADVISORSHARES PSYCHEDELICS ETF
PSIL ETF Overview
PSIL ETF (ADVISORSHARES PSYCHEDELICS ETF) is managed by Advisor Shares with $44.0M in net assets. PSIL expense ratio is 1.00%, holding 33 positions across sectors including Health Care. Inception date: 2021-09-15.
PSIL performance shows a YTD return of 32.95%. The 1-year return is 30.98%. PSIL dividend yield stands at 7.45%, paid quarterly.
PSIL top holdings include Definium Therapeutics, Inc. Common Shares (11.8%), Compass Pathways Plc Adr (11.2%), Cybin Inc. Common Shares (8.9%), Neurocrine Biosciences Inc (4.8%), Relmada Therapeutics Inc Common Stock (4.7%). Go to all PSIL holdings, PSIL sectors, or PSIL dividends.
PSIL can be compared against other funds. Use PSIL overlap to find shared positions, or PSIL vs another fund for a side-by-side view. PSIL alternatives are available via the screener, along with tax-loss harvesting opportunities.